Idenix pharmaceuticals, inc. – product pipeline review – 2012


Published on

2012 | | Idenix pharmaceuticals, inc. – product pipeline review – 2012

Published in: Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Idenix pharmaceuticals, inc. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012 You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s pharmaceuticals report, “Idenix Pharmaceuticals, Inc. -Product Pipeline Review - 2012” provides data on the Idenix Pharmaceuticals, Inc.’sresearch and development focus. The report includes information on currentdevelopmental pipeline, complete with latest updates, and features on discontinuedand dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Idenix Pharmaceuticals, Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from IdenixPharmaceuticals, Inc. and industry-specific third party sources, put together byGlobal Markets Direct’s team.Scope- Idenix Pharmaceuticals, Inc. - Brief Idenix Pharmaceuticals, Inc. overview includingbusiness description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Idenix Pharmaceuticals, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.Reasons to buy- Evaluate Idenix Pharmaceuticals, Inc.’s strategic position with total access to
  2. 2. detailed information on its product pipeline.- Assess the growth potential of Idenix Pharmaceuticals, Inc. in its therapy areas offocus.- Identify new drug targets and therapeutic classes in the Idenix Pharmaceuticals,Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline inthose areas.Table of contents:List of Tables 5List of Figures 5Idenix Pharmaceuticals, Inc. Snapshot 6Idenix Pharmaceuticals, Inc. Overview 6Key Information 6Key Facts 6Idenix Pharmaceuticals, Inc. – Research and Development Overview 7Key Therapeutic Areas 7Idenix Pharmaceuticals, Inc. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10Pipeline Products – Combination Treatment Modalities 11Idenix Pharmaceuticals, Inc. – Pipeline Products Glance 12Idenix Pharmaceuticals, Inc. Clinical Stage Pipeline Products 12Phase II Products/Combination Treatment Modalities 12Phase I Products/Combination Treatment Modalities 13Idenix Pharmaceuticals, Inc. – Early Stage Pipeline Products 14Pre-Clinical Products/Combination Treatment Modalities 14Idenix Pharmaceuticals, Inc. – Drug Profiles 15Additional Nucleotide Inhibitors 15Product Description 15Mechanism of Action 15R&D Progress 15IDX-184 + IDX-719 16Product Description 16Mechanism of Action 16
  3. 3. R&D Progress 16IDX-19368 + Ribavirin 17Product Description 17Mechanism of Action 17R&D Progress 17IDX077 18Product Description 18Mechanism of Action 18List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012IntelGenx Corp. – Product Pipeline Review – 2012Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012JADO Technologies GmbH – Product Pipeline Review – 2012
  4. 4. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012NeuroSearch A/S – Product Pipeline Review – 2012NovaDel Pharma, Inc. – Product Pipeline Review – 2012Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: